Lung Cancer Clinical Trials in San Antonio, TX

Lung Cancer Clinical Trials in San Antonio, TX

View the best 10 lung cancer medical studies in San Antonio, Texas. Access promising new therapies by applying to a San Antonio-based Lung Cancer clinical trial.

Trials in San Antonio, Texas

Here are the top 10 medical studies for lung cancer in San Antonio, Texas

Image of Children's Hospital of Alabama in Birmingham, United States.

Thoracotomy +1 More

Procedure

Recruiting2 awardsPhase 3
This trial compares the effect of open thoracic surgery to thoracoscopic surgery in treating patients with osteosarcoma that has spread to the lung.
Image of South Texas Accelerated Research Therapeutics (START) in San Antonio, United States.

LY4052031

Monoclonal Antibodies

Recruiting1 awardPhase 1
"This trial aims to determine if the drug LY4052031 is safe and effective in treating advanced solid tumors, such as urothelial cancer. The study is divided into two parts - phase I
Image of Carta - Clinical Associates in Research Therapeutics of America, LLC in San Antonio, United States.

Ponsegromab +1 More

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial tests Ponsegromab, a new drug, on cancer patients who are losing weight and have high GDF 15 levels. The drug aims to lower GDF 15 to improve appetite and reduce weight loss.
Image of Research Site in Mesa, United States.

Durvalumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 3
This trial is testing a new immunotherapy drug combo to see if it's more effective than just one of the drugs for treating lung cancer that has spread and can't be removed by surgery.
Image of NEXT Oncology in San Antonio, United States.

MDX2001

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
"This trial aims to understand how safe and well-tolerated MDX2001 is in patients with advanced solid tumors, as well as its effectiveness in fighting against the tumors."
Image of Research Site in Bellflower, United States.

Osimertinib

Tyrosine Kinase Inhibitor

Recruiting2 awardsPhase 3
This trial is testing whether adding chemotherapy to osimertinib will help people with non-small cell lung cancer that has a specific DNA mutation and has gotten worse despite osimertinib.
Image of Alaska Oncology and Hematology in Anchorage, United States.

Docetaxel +1 More

Anti-microtubule agent

Recruiting2 awardsPhase 3
This trial is testing a new drug, sigvotatug vedotin, against a standard drug, docetaxel, in patients with advanced lung cancer. The goal is to see if the new drug works better and to understand its side effects. Docetaxel (Taxotere) is a well-established chemotherapy agent used in the treatment of advanced non-small cell lung cancer (NSCLC), often after failure of first-line treatments.
Image of BRCR Medical Center, Inc. in Plantation, United States.

Olvimulogene Nanivacirepvec

Virus Therapy

Recruiting1 awardPhase 2
This trial is testing a new treatment for advanced lung cancer. It involves giving patients a virus called Olvi-Vec through an IV. After this, patients will receive chemotherapy and an immune checkpoint inhibitor.
Image of Hematology Oncology Associates of CNY, PC in East Syracuse, United States.

Adagrasib

Small Molecule Drug

Recruiting1 awardPhase 2
This trial tests a drug combo to treat advanced lung cancer with a genetic mutation.
Image of Dana Farber Cancer Institute in Boston, United States.

Sotorasib +1 More

Small Molecule Inhibitor

Recruiting1 awardPhase 1 & 2
This trial will study the safety and effectiveness of VS-6766 when used with sotorasib in patients with a specific type of lung cancer.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.